Cyclin J pseudogene 1 (CCNJP1)

**Cyclin J pseudogene 1 (CCNJP1) is a pseudogene; thus, it does not encode a functional protein product.** Pseudogenes are generally regarded as nonfunctional genomic sequences similar to known genes but rendered incapable of normal gene expression or protein function by disabling mutations such as frameshifts or premature stop codons. Unlike protein-coding genes, pseudogenes do not serve as direct molecular targets for drugs or therapeutic interventions[5]. No biological function, disease association, or pharmacological relevance has been demonstrated for CCNJP1. There is no evidence that this pseudogene is involved in cell cycle control, immune modulation, or any disease process. **Key context:** - Pseudogenes are often catalogued in genomic databases for completeness but are not considered actionable or druggable biological targets[5]. - The cyclin gene family (such as Cyclin J, Cyclin D1, etc.) includes several therapeutically relevant proteins involved in cell cycle regulation[2][3][6]. However, CCNJP1 specifically refers to a pseudogene, not to the active Cyclin J protein or its gene. - No curated sources or gene databases (such as GeneCards, UniProt, NCBI Gene) report functional information or disease associations for CCNJP1, confirming its nature as a non-functional pseudogene. **Summary:** **Cyclin J pseudogene 1 (CCNJP1) is not a functional protein or therapeutic target; it is a non-functional pseudogene.** This entry should be handled as non-actionable for target/drug development purposes[5].

None